As of 2033, the Amyotrophic Lateral Sclerosis Market is Expected to Reach US$ 1332.22 Million – Future Market Insights, Inc.
4 min read
NEWARK, Del:
According to a recent FMI study, the global Amyotrophic Lateral Sclerosis Market is expected to reach US$ 743.90 Million in 2023 and US$ 1332.22 Million by 2023 to 2033, at a CAGR of 6%. The market for Amyotrophic Lateral Sclerosis registered a CAGR of 4% in the historical period 2017-2022.
Growth of the Amyotrophic Lateral Sclerosis market can be attributed to the rising geriatric population, growing awareness about ALS, and increasing incidence rate. In addition to this, various measures adopted by the government or healthcare organizations to spread awareness are further pushing the market growth.
In June 2022, the United States Food and Drug Administration (FDA) launched an action plan for Rare Neurodegenerative Diseases including Amyotrophic Lateral Sclerosis (ALS). This action plan is the five-year strategy being implemented by the United States FDA with the motive to improve and extend the lives of people living with rare neurodegenerative diseases. With the implementation of the plan, advancements are taking place in the development of effective medical products to offer novel treatments to all patients.
Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-16174
In terms of market share and revenue, the North American market is predicted to be the most lucrative market during the forecast period with a revenue share of 20%. The region’s growth is driven by the presence of various key players which are working on research and development of effective solutions. For instance, in May 2022, Mitsubishi Tanabe Pharma America received the United States Food and Drug Administration Approval for RADICAVA ORS (edaravone) for the Treatment of amyotrophic lateral sclerosis.
Key Takeaways from the Market Study
- From 2017-2022, the Amyotrophic Lateral Sclerosis market grew at CAGR of 4%.
- The global Amyotrophic Lateral Sclerosis market is expected to grow with a 6% CAGR during 2023-2033.
- As of 2033, the Amyotrophic Lateral Sclerosis market is expected to reach US$ 1332.22 Million
- According to the FMI analysis, Hospital pharmacies account for the largest market share.
- Stem cell therapy is expected to show the highest CAGR owing to the increasing demand for new approaches.
- North America is expected to possess 20% market share for Amyotrophic Lateral Sclerosis market.
- The Asia Pacific market is predicted to increase significantly throughout the forecast period, with a CAGR of 5% during the forecast period.
Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-16174
“An inclination of population towards a stationary lifestyle and increasing geriatric population has increased the demand for targeted and indicating treatment options, which are driving the global amyotrophic lateral sclerosis market.” says an FMI analyst
Market Competition
Key players in the Amyotrophic Lateral Sclerosis market are Mitsubishi Tanabe Pharma Corporation; Otsuka Pharmaceutical Co., Ltd.; BrainStorm Therapeutics; Biogen Inc.; Corestem; AB Science; F.Hoffmann-La Roche AG; Biohaven Pharmaceutical; Sun Pharmaceutical; and Ionis Pharmaceuticals, Inc.
- In June 2021, CRISPR Therapeutics and Capsida Biotherapeutics Inc. entered into a strategic partnership to research, develop, manufacture and commercialize in vivo gene editing therapies using CRISPR technology delivered with engineered AAV vectors for the treatment of familial amyotrophic lateral sclerosis (ALS) and Friedreich’s ataxia. Such partnerships are likely to bolster market growth.
Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/16174
Key Segments Profiled in the Amyotrophic Lateral Sclerosis Industry Survey
Treatment:
- Medication
- Stem Cell Therapy
- Others
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Others
Region:
- North America
- Latin America
- Europe
- Asia Pacific
- MEA
Table of Content
- Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
- Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
View Full Report @ https://www.futuremarketinsights.com/reports/amyotrophic-lateral-sclerosis-market
Have a Look at Related Research Reports of Healthcare Domain:
Dental Lasers Market Size – The dental lasers market size is projected to be valued at US$ 492.2 million in 2023 and is expected to rise to US$ 737.4 million by 2033.
Esophagoscopes & Gastroscopes Market Growth – The global esophagoscopes and gastroscopes market currently stands at US$ 1.2 billion and is predicted to exhibit a CAGR of 5.4%. The market is predicted to rake in revenue worth US$ 2.0 billion by the end of 2033
3D Printed Medical Devices Market Trends – The 3D printed medical devices market is likely to expand its roots at a robust CAGR of 16.3% during the forecast period. The market holds a share of US$ 799.8 million in 2023, while it is anticipated to cross a value of US$ 3.6 billion by 2033.
PPG Biosensors Market Scope – Newly-released PPG biosensors Market analysis report by Future Market Insights shows that the global market size of PPG biosensors in 2022 was held at US$ 417.3 Million
Fucosidosis Therapeutics Market Forecast – The global Fucosidosis Therapeutics Market is expected to garner a market value of US$ 10 Million in 2023 and is expected to accumulate a market value of US$ 17.91 Million by registering a CAGR of 6% in the forecast period 2023 to 2033
About Us :
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate,
200 Continental Drive,
Suite 401, Newark,
Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
